Research Interests 【 display / non-display 】

Research Interests 【 display / non-display 】

Graduating School 【 display / non-display 】

Graduating School 【 display / non-display 】

• 1998.04

  -

  2002.03

  Hokuriku University   Faculty of Pharmaceutical Science   Graduated

Graduate School 【 display / non-display 】

Graduate School 【 display / non-display 】

• 2004.04

  -

  2007.03

  Chiba University    Doctor's Course  Completed

Campus Career 【 display / non-display 】

Campus Career 【 display / non-display 】

• 2024.04

  -

  Now

  Akita University   Hospital   Pharmaceutical Management Center   Associate Professor  

• 2022.04

  -

  2024.03

  Akita University   Hospital   Pharmaceutical Management Center   Lecturer  

• 2016.04

  -

  2022.03

  Akita University   Hospital   Pharmaceutical Management Center   Assistant Professor  

• 2013.11

  -

  2016.03

  Akita University   Hospital   Center of Advanced Treatment for Kidney Disease   Specially-appointed Assistant Professor  

Research Achievements 【 display / non-display 】

Research Achievements 【 display / non-display 】

◆Original paper【 display / non-display 】

To the head of this page.▲

◆Original paper【 display / non-display 】

Impact of persistent preformed and de novo donor-specific antibodies detected at 1 year after kidney transplantation on long-term graft survival in Japan: a retrospective study.

Fujiyama N, Satoh S, Saito M, Numakura K, Inoue T, Yamamoto R, Saito T, Kanda S, Narita S, Mitobe Y, Habuchi T.

Clinical and experimental nephrology   23 ( 12 ) 1398 - 1406   2019.09  [Refereed]

Research paper (journal)   Domestic Co-author

DOI

Association of immunosuppressive agents and cytomegalovirus infection with de novo donor-specific antibody development within 1 year after renal transplantation.

Fujiyama N, Satoh S, Saito M, Numakura K, Inoue T, Yamamoto R, Saito T, Nara T, Kanda S, Narita S, Kagaya H, Miura M, Habuchi T.

International immunopharmacology   76   105881   2019.09  [Refereed]

Research paper (journal)   Domestic Co-author

DOI

Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.

Igarashi R, Inoue T, Fujiyama N, Tsuchiya N, Numakura K, Kagaya H, Saito M, Narita S, Satoh S, Niioka T, Miura M, Habuchi T.

Medical oncology   35 ( 4 ) 51   2018.03  [Refereed]

Research paper (journal)   Domestic Co-author

DOI

Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients.

Numakura K, Fujiyama N, Takahashi M, Igarashi R, Tsuruta H, Maeno A, Huang M, Saito M, Narita S, Inoue T, Satoh S, Tsuchiya N, Niioka T, Miura M, Habuchi T.

Oncotarget   9 ( 38 ) 25277 - 25284   2018.03  [Refereed]

Research paper (journal)   Domestic Co-author

DOI

To the head of this page.▲

◆Other【 display / non-display 】

To the head of this page.▲

◆Other【 display / non-display 】

Method for Distinguishing Identical and Non-Identical Pills in Unit-Dose Packages

Tatsumi Shuei, Zou Min, Sasaki Katsuya, Kagaya Hideaki, Fujiyama Nobuhiro, Kageyama Yoichi

Proceedings of IIAE Annual Conference ( The Institute of Industrial Applications Engineers )  2024 ( 0 ) 69 - 70   2024

DOI CiNii Research

Automatic Classification of Colored Pills in ODP-based Machine Learning

Tatsumi Shuei, Zou Min, Sasaki Katsuya, Kagaya Hideaki, Fujiyama Nobuhiro, Kageyama Yoichi

Proceedings of IIAE Annual Conference ( The Institute of Industrial Applications Engineers )  2023 ( 0 ) 17 - 18   2023

DOI CiNii Research